FI881061A7 - Hitaasti vapauttavia valmisteita ruoansulatuskanavan ulkopuolisesti annettaviksi ja niiden käyttö. - Google Patents

Hitaasti vapauttavia valmisteita ruoansulatuskanavan ulkopuolisesti annettaviksi ja niiden käyttö. Download PDF

Info

Publication number
FI881061A7
FI881061A7 FI881061A FI881061A FI881061A7 FI 881061 A7 FI881061 A7 FI 881061A7 FI 881061 A FI881061 A FI 881061A FI 881061 A FI881061 A FI 881061A FI 881061 A7 FI881061 A7 FI 881061A7
Authority
FI
Finland
Prior art keywords
slow
parenteral administration
release preparations
preparations
release
Prior art date
Application number
FI881061A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI881061L (fi
FI881061A0 (fi
Inventor
Volker Dietrich Arendt
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI881061A0 publication Critical patent/FI881061A0/fi
Publication of FI881061L publication Critical patent/FI881061L/fi
Publication of FI881061A7 publication Critical patent/FI881061A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y10S530/814—Cellulose or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI881061A 1987-03-09 1988-03-08 Hitaasti vapauttavia valmisteita ruoansulatuskanavan ulkopuolisesti annettaviksi ja niiden käyttö. FI881061A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/023,427 US4857505A (en) 1987-03-09 1987-03-09 Sustained release compositions for parenteral administration and their use

Publications (3)

Publication Number Publication Date
FI881061A0 FI881061A0 (fi) 1988-03-08
FI881061L FI881061L (fi) 1988-09-10
FI881061A7 true FI881061A7 (fi) 1988-09-10

Family

ID=21815030

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881061A FI881061A7 (fi) 1987-03-09 1988-03-08 Hitaasti vapauttavia valmisteita ruoansulatuskanavan ulkopuolisesti annettaviksi ja niiden käyttö.

Country Status (14)

Country Link
US (1) US4857505A (enExample)
EP (1) EP0281809B1 (enExample)
JP (1) JPS63253030A (enExample)
AT (1) ATE92329T1 (enExample)
AU (1) AU603189B2 (enExample)
CA (1) CA1318249C (enExample)
DE (1) DE3882748D1 (enExample)
DK (1) DK124288A (enExample)
FI (1) FI881061A7 (enExample)
GR (1) GR3009565T3 (enExample)
HU (1) HU201681B (enExample)
IL (1) IL85476A (enExample)
NZ (1) NZ223715A (enExample)
ZA (1) ZA881657B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336506A (en) * 1986-07-03 1994-08-09 Advanced Magnetics Inc. Targeting of therapeutic agents using polysaccharides
US5011918A (en) * 1987-10-26 1991-04-30 National Starch And Chemical Investment Holding Corporation Polysaccharides containing aromatic aldehydes and their derivatization via amine-aldehyde interactions
US4929670A (en) * 1987-10-26 1990-05-29 National Starch And Chemical Investment Holding Corporation Polysaccharides containing aromatic aldehydes and their derivatization via amine-aldehyde interactions
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
US5174998A (en) * 1988-11-30 1992-12-29 Nisshin Flour Milling Co., Ltd. Sustained release compositions using as matrix hemicellulose extracted from wheat bran
US5032401A (en) * 1989-06-15 1991-07-16 Alpha Beta Technology Glucan drug delivery system and adjuvant
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5374620A (en) * 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
CA2070672C (en) * 1990-10-18 2002-10-08 Kazuo Akima Compound of medicinal ingredient and hyaluronic acid and process for producing the same
US5733891A (en) * 1990-10-18 1998-03-31 Shiseido Co., Ltd. Compound for medicinal ingredient and hyaluronic acid and process for producing the same
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
EP0563249B1 (en) * 1990-12-19 1997-04-23 Advanced Magnetics Incorporated Targeting of therapeutic agents using polysaccharides
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US6284727B1 (en) 1993-04-07 2001-09-04 Scios, Inc. Prolonged delivery of peptides
US5614487A (en) * 1993-05-28 1997-03-25 Genentech, Inc. Sustained release pharmaceutical composition
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
MXPA02000404A (es) * 1999-07-12 2004-05-21 Grandis Biotech Gmbh Formulaciones de hormona de crecimiento.
CN1095472C (zh) * 2000-04-17 2002-12-04 上海复康医药科技发展有限公司 叶酸－多聚糖复合物，其制备方法和以该复合物为活性成分的药物组合物
DK2279755T3 (da) * 2001-10-10 2014-05-26 Ratiopharm Gmbh Remodellering og glycokonjugering af fibroblastvækstfaktor (FGF)
RU2200216C1 (ru) * 2002-05-08 2003-03-10 Санкт-Петербургский государственный технологический университет растительных полимеров Волокнистый материал для защиты от бытовых насекомых
CN100475267C (zh) * 2002-07-09 2009-04-08 桑多斯股份公司 含甘氨酸的高浓度人生长激素液体制剂
CN113398273B (zh) * 2021-05-14 2022-07-19 广西壮族自治区中国科学院广西植物研究所 木聚糖衍生物作为亲水性缓释材料在制备药物缓释片中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH514650A (fr) * 1967-05-23 1971-10-31 Pharmacia Ab Procédé de préparation de dérivés de peptides insolubles dans l'eau
US4003792A (en) * 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
US3947352A (en) * 1974-05-31 1976-03-30 Pedro Cuatrecasas Polysaccharide matrices for use as adsorbents in affinity chromatography techniques
CA1167403A (en) * 1979-07-10 1984-05-15 Unilever Limited Microbial heteropolysaccharide
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
US4521409A (en) * 1983-10-03 1985-06-04 Cornell Research Foundation, Inc. Use of growth hormone to enhance ruminant mammary development
US4585754A (en) * 1984-01-09 1986-04-29 Valcor Scientific, Ltd. Stabilization of proteins and peptides by chemical binding with chondroitin
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
PT83095B (en) * 1985-07-30 1987-12-23 Int Minerals & Chem Corp Method for the stabilization of growth promoting hormones using polyoxyethylene-polyoxypropylene copolymers
CA1285874C (en) * 1985-08-23 1991-07-09 Thomas Harry Ferguson Injectable sustained release formulation
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.

Also Published As

Publication number Publication date
DK124288A (da) 1988-09-10
US4857505A (en) 1989-08-15
JPS63253030A (ja) 1988-10-20
FI881061L (fi) 1988-09-10
HU201681B (en) 1990-12-28
EP0281809A2 (en) 1988-09-14
NZ223715A (en) 1990-11-27
AU603189B2 (en) 1990-11-08
CA1318249C (en) 1993-05-25
IL85476A0 (en) 1988-07-31
ATE92329T1 (de) 1993-08-15
AU1277688A (en) 1988-09-08
IL85476A (en) 1991-08-16
EP0281809A3 (en) 1990-06-06
GR3009565T3 (enExample) 1994-02-28
FI881061A0 (fi) 1988-03-08
ZA881657B (en) 1988-09-06
HUT47220A (en) 1989-02-28
DE3882748D1 (de) 1993-09-09
EP0281809B1 (en) 1993-08-04
DK124288D0 (da) 1988-03-08

Similar Documents

Publication Publication Date Title
FI881061A7 (fi) Hitaasti vapauttavia valmisteita ruoansulatuskanavan ulkopuolisesti annettaviksi ja niiden käyttö.
NO883591D0 (no) Dermal administreringsform.
NL300038I2 (nl) Thiazolidinedionderivaten, alsmede bereiding en toepassing daarvan.
DE68911473D1 (de) Arzneimittelformulierungen.
FI935071A7 (fi) Uudet perhydroisoindolit, niiden valmistus ja niitä sisältävät farmase uttiset valmisteet
DE68910833D1 (de) Polylactid-zubereitungen.
IT1219940B (it) Benzo-b-pirani e piranopiridone,loro preparazione e loro impiego come medicamenti
DK556788D0 (da) Tetracyclinholdige, farmaceutiske praeparater med kontrolleret frigivelseshastighed
DE3873127D1 (de) Therapeutische praeparate.
IS3339A7 (is) Ný efnablanda lyfja
FI873630A7 (fi) Stabilt farmaceutiskt preparat.
DK184087A (da) Farmaceutiske praeparater med forbedret biotilgaengelighed
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
FI885592A7 (fi) Aryloksifenyylipropyyliamiinit, niiden valmistus ja käyttö
DE3682960D1 (de) Pharmazeutische praeparate.
DE3576118D1 (de) Pharmazeutische praeparate.
PH24836A (en) Alkyl-substituted n-benzopyranyllactams,their use and pharmaceutical preparations based on these compounds
FI874382A7 (fi) Farmaseuttiset valmisteet.
DK527487A (da) Farmaceutiske praeparater med forlaenget afgivelse
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
FI881238A7 (fi) Farmaceutisk beredning.
FI883747A7 (fi) Topiskt anvaendbara farmaceutiska preparat.
IT8722218A0 (it) Ftalazino derivati ad attivita'farmaceutica.
FI874875A7 (fi) Uusia 2,6-diamino-3 -halogeeenibentsyylipyridiinejä ja menetelmä niiden valmistamiseksi sekä niiden käyttö lääkevalmisteissa.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: AMERICAN CYANAMID COMPANY